Medicament Pertuzumab + trastuzumab L01FY01 subcutaneous injection solution AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Procurement object

  • What is being procured: Medicament Pertuzumab + trastuzumab L01FY01 subcutaneous injection solution.
  • Main technical requirements, characteristics:
    • The medicament must comply with the technical specification provided in Annex 1 (active substance, dosage form, dose size).
    • Minimum shelf life: At the time of goods handover, at least 50% of the shelf life must remain.
    • The offered medicament must have a valid marketing authorization in the Republic of Estonia.
      *…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

297665_ESPD_v2.0_laiendatud.xml

297665_hankepass_taiendavate_selgitustega.pdf

297665_hindamiskriteeriumid.pdf

297665_vastavustingimused.pdf

297665.zip

Juhised pakkujale.pdf

Lisa 1.xls

Lisa 2_Raamlepingu projekt.pdf

Lisa_3_Vorm_III_Avaldus.doc

Lisa_3_Vorm II_Volikiri.doc

Lisa 3_Vorm I_Ühispakkujate volikiri.doc

Ready to get started?

Subscribe and enjoy all the benefits every day!